Close Menu

NEW YORK (GenomeWeb) – The US Food and Drug Administration today issued a draft guidance document that aims to make it easier to get oncology-class labeling on companion diagnostic tests for therapeutic products.

Broadly, the initiative aims to address labeling challenges associated with developing companion diagnostics that can help target the delivery of cancer drugs, FDA Commissioner Scott Gottlieb said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Newsweek discusses the privacy issues raised by digital medicine.

A group of statisticians wants to eliminate researchers' reliance on 'statistical significance,' according to NPR.

In Nature this week: genetic analysis of Anatolian farmers, cotton genome analysis, and more.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.